The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells

por Gutknecht, Michael, Geiger, Julian, Joas, Simone, Dörfel, Daniela, Salih, Helmut R, Müller, Martin R, Grünebach, Frank, Rittig, Susanne M
Publicado 2015

Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells

por Gutknecht, Michael, Geiger, Julian, Joas, Simone, Dörfel, Daniela, Salih, Helmut R., Müller, Martin R., Grünebach, Frank, Rittig, Susanne M.
Publicado 2016

Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report

por Dorn, Christiane, Bugl, Stefanie, Malenke, Elke, Müller, Martin R, Weisel, Katja C, Vogel, Ulrich, Horger, Marius, Kanz, Lothar, Kopp, Hans-Georg
Publicado 2014

C‐Cbl regulates c‐MPL receptor trafficking and its internalization

por Märklin, Melanie, Tandler, Claudia, Kopp, Hans‐Georg, Hoehn, Kyle L., Quintanilla‐Martinez, Leticia, Borst, Oliver, Müller, Martin R., Saur, Sebastian J.
Publicado 2020

Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by γ-Secretase Inhibitor IX

por Palagani, Vindhya, El Khatib, Mona, Kossatz, Uta, Bozko, Przemyslaw, Müller, Martin R., Manns, Michael P., Krech, Till, Malek, Nisar P., Plentz, Ruben R.
Publicado 2012

Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia

por Märklin, Melanie, Fuchs, Alexander R., Tandler, Claudia, Heitmann, Jonas S., Salih, Helmut R., Kauer, Joseph, Quintanilla-Martinez, Leticia, Wirths, Stefan, Kopp, Hans-Georg, Müller, Martin R.
Publicado 2020

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

por Muenchow, Alina, Weller, Sandra, Hinterleitner, Clemens, Malenke, Elke, Bugl, Stefanie, Wirths, Stefan, Müller, Martin R., Schulze-Osthoff, Klaus, Aulitzky, Walter E., Kopp, Hans-Georg, Essmann, Frank
Publicado 2020

Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy

por Rittig, Susanne M., Haentschel, Maik, Weimer, Katrin J., Heine, Annkristin, Müller, Martin R., Brugger, Wolfram, Horger, Marius S., Maksimovic, Olga, Stenzl, Arnulf, Hoerr, Ingmar, Rammensee, Hans-Georg, Holderried, Tobias A., Kanz, Lothar, Pascolo, Steve, Brossart, Peter
Publicado 2015

NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia

por Märklin, Melanie, Heitmann, Jonas S., Fuchs, Alexander R., Truckenmüller, Felicia M., Gutknecht, Michael, Bugl, Stefanie, Saur, Sebastian J., Lazarus, Juliane, Kohlhofer, Ursula, Quintanilla-Martinez, Leticia, Rammensee, Hans-Georg, Salih, Helmut R., Kopp, Hans-Georg, Haap, Michael, Kirschniak, Andreas, Kanz, Lothar, Rao, Anjana, Wirths, Stefan, Müller, Martin R.
Publicado 2017

NFATc1 affects mouse splenic B cell function by controlling the calcineurin–NFAT signaling network

por Bhattacharyya, Sankar, Deb, Jolly, Patra, Amiya K., Thuy Pham, Duong Anh, Chen, Wen, Vaeth, Martin, Berberich-Siebelt, Friederike, Klein-Hessling, Stefan, Lamperti, Edward D., Reifenberg, Kurt, Jellusova, Julia, Schweizer, Astrid, Nitschke, Lars, Leich, Ellen, Rosenwald, Andreas, Brunner, Cornelia, Engelmann, Swen, Bommhardt, Ursula, Avots, Andris, Müller, Martin R., Kondo, Eisaku, Serfling, Edgar
Publicado 2011